NATIONAL HEALTHCARE CORP (NHC) Stock Fundamental Analysis

NYSEARCA:NHC • US6359061008

169.69 USD
+1.36 (+0.81%)
At close: Feb 13, 2026
169.69 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, NHC scores 6 out of 10 in our fundamental rating. NHC was compared to 102 industry peers in the Health Care Providers & Services industry. While NHC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NHC has a expensive valuation and it also scores bad on growth. NHC also has an excellent dividend rating. These ratings would make NHC suitable for dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • NHC had positive earnings in the past year.
  • In the past year NHC had a positive cash flow from operations.
  • Each year in the past 5 years NHC has been profitable.
  • In the past 5 years NHC always reported a positive cash flow from operatings.
NHC Yearly Net Income VS EBIT VS OCF VS FCFNHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • The Return On Assets of NHC (6.44%) is better than 86.27% of its industry peers.
  • NHC's Return On Equity of 9.62% is fine compared to the rest of the industry. NHC outperforms 69.61% of its industry peers.
  • NHC has a Return On Invested Capital of 7.14%. This is in the better half of the industry: NHC outperforms 67.65% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NHC is significantly below the industry average of 8.98%.
  • The last Return On Invested Capital (7.14%) for NHC is above the 3 year average (3.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.44%
ROE 9.62%
ROIC 7.14%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
NHC Yearly ROA, ROE, ROICNHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 6.75%, NHC belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
  • NHC's Profit Margin has improved in the last couple of years.
  • The Operating Margin of NHC (8.27%) is better than 75.49% of its industry peers.
  • NHC's Operating Margin has improved in the last couple of years.
  • NHC has a better Gross Margin (38.55%) than 68.63% of its industry peers.
  • In the last couple of years the Gross Margin of NHC has remained more or less at the same level.
Industry RankSector Rank
OM 8.27%
PM (TTM) 6.75%
GM 38.55%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
NHC Yearly Profit, Operating, Gross MarginsNHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

  • NHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NHC has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NHC has been increased compared to 5 years ago.
  • The debt/assets ratio for NHC is higher compared to a year ago.
NHC Yearly Shares OutstandingNHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NHC Yearly Total Debt VS Total AssetsNHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 5.15 indicates that NHC is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of NHC (5.15) is better than 86.27% of its industry peers.
  • NHC has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.50, NHC belongs to the best of the industry, outperforming 89.22% of the companies in the same industry.
  • A Debt/Equity ratio of 0.06 indicates that NHC is not too dependend on debt financing.
  • The Debt to Equity ratio of NHC (0.06) is better than 77.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.5
Altman-Z 5.15
ROIC/WACC0.84
WACC8.55%
NHC Yearly LT Debt VS Equity VS FCFNHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • NHC has a Current Ratio of 1.75. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.75, NHC is doing good in the industry, outperforming 68.63% of the companies in the same industry.
  • A Quick Ratio of 1.72 indicates that NHC should not have too much problems paying its short term obligations.
  • NHC's Quick ratio of 1.72 is fine compared to the rest of the industry. NHC outperforms 72.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.72
NHC Yearly Current Assets VS Current LiabilitesNHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • NHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.77%.
  • The Earnings Per Share has been growing by 8.03% on average over the past years. This is quite good.
  • Looking at the last year, NHC shows a very strong growth in Revenue. The Revenue has grown by 21.12%.
  • The Revenue has been growing slightly by 5.58% on average over the past years.
EPS 1Y (TTM)-18.77%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-8.28%
Revenue 1Y (TTM)21.12%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%12.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHC Yearly Revenue VS EstimatesNHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 26.19, the valuation of NHC can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as NHC.
  • Compared to an average S&P500 Price/Earnings ratio of 27.19, NHC is valued at the same level.
Industry RankSector Rank
PE 26.19
Fwd PE N/A
NHC Price Earnings VS Forward Price EarningsNHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 63.73% of the companies listed in the same industry.
  • 69.61% of the companies in the same industry are more expensive than NHC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.93
EV/EBITDA 13.29
NHC Per share dataNHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The excellent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.26
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

  • NHC has a Yearly Dividend Yield of 1.51%.
  • NHC's Dividend Yield is rather good when compared to the industry average which is at 0.48. NHC pays more dividend than 88.24% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, NHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

  • The dividend of NHC has a limited annual growth rate of 3.30%.
  • NHC has paid a dividend for at least 10 years, which is a reliable track record.
  • NHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
NHC Yearly Dividends per shareNHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • NHC pays out 37.72% of its income as dividend. This is a sustainable payout ratio.
  • NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.72%
EPS Next 2YN/A
EPS Next 3YN/A
NHC Yearly Income VS Free CF VS DividendNHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M
NHC Dividend Payout.NHC Dividend Payout, showing the Payout Ratio.NHC Dividend Payout.PayoutRetained Earnings

NATIONAL HEALTHCARE CORP

NYSEARCA:NHC (2/13/2026, 8:04:00 PM)

After market: 169.69 0 (0%)

169.69

+1.36 (+0.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-31
Earnings (Next)02-25
Inst Owners62.44%
Inst Owner Change3.98%
Ins Owners7.07%
Ins Owner Change-0.2%
Market Cap2.63B
Revenue(TTM)1.50B
Net Income(TTM)101.25M
Analysts60
Price TargetN/A
Short Float %2.68%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP37.72%
Div Incr Years11
Div Non Decr Years11
Ex-Date03-31
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.19
Fwd PE N/A
P/S 1.76
P/FCF 17.93
P/OCF 14.55
P/B 2.5
P/tB 3.05
EV/EBITDA 13.29
EPS(TTM)6.48
EY3.82%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.46
FCFY5.58%
OCF(TTM)11.67
OCFY6.88%
SpS96.69
BVpS67.85
TBVpS55.58
PEG (NY)N/A
PEG (5Y)3.26
Graham Number99.46
Profitability
Industry RankSector Rank
ROA 6.44%
ROE 9.62%
ROCE 9.63%
ROIC 7.14%
ROICexc 9.28%
ROICexgc 11.49%
OM 8.27%
PM (TTM) 6.75%
GM 38.55%
FCFM 9.79%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.5
Debt/EBITDA 0.39
Cap/Depr 76.7%
Cap/Sales 2.28%
Interest Coverage 250
Cash Conversion 107.3%
Profit Quality 145.05%
Current Ratio 1.75
Quick Ratio 1.72
Altman-Z 5.15
F-Score6
WACC8.55%
ROIC/WACC0.84
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.77%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-8.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.12%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%12.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.96%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y102.62%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y85.86%
OCF growth 3Y19.81%
OCF growth 5Y1.4%

NATIONAL HEALTHCARE CORP / NHC FAQ

What is the fundamental rating for NHC stock?

ChartMill assigns a fundamental rating of 6 / 10 to NHC.


Can you provide the valuation status for NATIONAL HEALTHCARE CORP?

ChartMill assigns a valuation rating of 3 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Overvalued.


How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?

NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.


How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?

The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 37.72%.